Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Novartis Ag (NVSEF) FCF Margin (2016 - 2025)

Historic FCF Margin for Novartis Ag (NVSEF) over the last 17 years, with Q4 2025 value amounting to 346.98%.

  • Novartis Ag's FCF Margin rose 3108600.0% to 346.98% in Q4 2025 from the same period last year, while for Dec 2025 it was 629.7%, marking a year-over-year increase of 5919700.0%. This contributed to the annual value of 37.94% for FY2025, which is 2100.0% up from last year.
  • Latest data reveals that Novartis Ag reported FCF Margin of 346.98% as of Q4 2025, which was up 3108600.0% from 948.63% recorded in Q3 2025.
  • Novartis Ag's 5-year FCF Margin high stood at 948.63% for Q3 2025, and its period low was 15.21% during Q1 2022.
  • Its 5-year average for FCF Margin is 154.43%, with a median of 38.31% in 2021.
  • Its FCF Margin has fluctuated over the past 5 years, first plummeted by -159100bps in 2023, then surged by 8971100bps in 2025.
  • Over the past 5 years, Novartis Ag's FCF Margin (Quarter) stood at 32.84% in 2021, then grew by 27bps to 41.76% in 2022, then crashed by -38bps to 25.85% in 2023, then soared by 40bps to 36.12% in 2024, then surged by 861bps to 346.98% in 2025.
  • Its FCF Margin was 346.98% in Q4 2025, compared to 948.63% in Q3 2025 and 653.13% in Q2 2025.